The small-volume parenteral (SVP) market is expected to grow at a CAGR of 7.8% during the forecast period of 2023 to 2031. The SVP market is poised for significant growth due to factors such as the increasing prevalence of chronic diseases, advances in drug development, and demographic shifts. In spite of regulatory obstacles, the market is adapting to satisfy quality ...
Read More »